In The News Posted December 12, 2019 Share Posted December 12, 2019 BENGALURU, Indien, 12. Dezember 2019 /PRNewswire/ -- Biocon Biologics, ein voll integrierter, globaler Entwickler von Biosimilars, hat bei seinem Symposium unter dem Titel ‚100 years of Insulin – Delivering on Universal Access & Equitable Care' im Rahmen des IDF Congress 2019 in Busan... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.